The research evidence supporting BPC-157 spans over 100 peer-reviewed publications
Additionally, BPC-157 has been shown to regulate inflammatory responses by reducing pro-inflammatory cytokines and stimulating the release of growth factors vital for healing
Future work should take into consideration recent advances in methods for handling, and analysis of, human tissue, new mouse models (e.g., APP-NLF knockin mice) (Saito et al., 2014), and genetically diverse mouse strains (Neuner et al., 2019
Etamicastat, chronically administered in drinking water, also significantly reduced both blood pressure and urinary NE excretion but increased urinary DA excretion in the SHR [4]
"Recent Applications of Retro-Inverso Peptides"